Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement
- PMID: 39808425
- DOI: 10.1001/jama.2024.27154
Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement
Abstract
Importance: Osteoporotic fractures are associated with psychological distress, subsequent fractures, loss of independence, reduced ability to perform activities of daily living, and death.
Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the evidence on the benefits and harms of screening for osteoporosis to prevent fractures in adults 40 years or older with no known diagnosis of osteoporosis or history of fragility fracture.
Population: Adults 40 years or older without known osteoporosis or history of fragility fractures.
Evidence assessment: The USPSTF concludes with moderate certainty that screening for osteoporosis to prevent osteoporotic fractures in women 65 years or older has moderate net benefit. The USPSTF concludes with moderate certainty that screening for osteoporosis to prevent osteoporotic fractures in postmenopausal women younger than 65 years at increased risk has moderate net benefit. The USPSTF concludes that the evidence is insufficient and the balance of benefits and harms for screening for osteoporosis to prevent osteoporotic fractures in men cannot be determined.
Recommendation: The USPSTF recommends screening for osteoporosis to prevent osteoporotic fractures in women 65 years or older. (B recommendation) The USPSTF recommends screening for osteoporosis to prevent osteoporotic fractures in postmenopausal women younger than 65 years who are at increased risk for an osteoporotic fracture as estimated by clinical risk assessment. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for osteoporosis to prevent osteoporotic fractures in men. (I statement).
Comment in
-
Fracture Risk Assessment as a Component of Osteoporosis Screening-Easier Said Than Done.JAMA. 2025 Feb 11;333(6):468-469. doi: 10.1001/jama.2024.27416. JAMA. 2025. PMID: 39808424 No abstract available.
-
Research That Could Broaden the Scope of Bone Density Screening.JAMA Netw Open. 2025 Jan 2;8(1):e2460746. doi: 10.1001/jamanetworkopen.2024.60746. JAMA Netw Open. 2025. PMID: 39808435 No abstract available.
-
Beyond the AJR: Commentary on Updated USPSTF Osteoporosis Screening Recommendation Statement.AJR Am J Roentgenol. 2025 Aug;225(2):e2532969. doi: 10.2214/AJR.25.32969. Epub 2025 Apr 2. AJR Am J Roentgenol. 2025. PMID: 40172170 No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
